Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia

NCT05773729 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

β-thalassemia

Interventions

GENETIC: BD211

Sponsor

Shanghai BDgene Co., Ltd.

Collaborators

[object Object]